Govt Job: For M.Pharm as Junior Associate at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educators of the then combined state of Punjab, who, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, considered the institutions of scientific knowledge as temples of learning and places of pilgrimage.

Post: Junior Materiovigilance Associate

Applications are invited on a plain paper for the contractual post of Junior Materiovigilance Associate under NCC-PvPI, IPC Regional Center, Department of Pharmacology, Chandigarh-160012.

Qualification : Graduation in Biomedical Engineering / Clinical Engineering or Master’s in Pharmacy

Desirable Experience: Good knowledge of Computers

Age: Not exceeding 28 years

Pay Scale: Rs. 26,250/- per month

Nature of Job: Purely Contractual (As per GeM contract)

Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 18th December 2022 through email at recruitmentmanpowereplpgimer@gmail.com

The short-listed candidates will be intimated through email to attend the personal or virtual interview.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework